WEG
MRNA icon

World Equity Group’s Moderna MRNA Stock Holding History

World Equity Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,430
Closed -$406K – 338
2022
Q3 		$406K Hold
3,430
– – 0.1% 194
2022
Q2 		$490K Buy
3,430
+80
+2% +$11.4K 0.12% 179
2022
Q1 		$577K Buy
+3,350
New +$564K 0.12% 189

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

World Equity Group's MRNA Position: Q4 2022 in Review

World Equity Group sold out of Moderna (MRNA) in Q4 2022, closing a stake of 3,430 shares — an estimated $406K sold.

World Equity Group first reported a position in MRNA in Q1 2022 and held it in 3 quarters. The position peaked at $577K in Q1 2022. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • World Equity Group reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • World Equity Group sold 3,430 Moderna shares in Q4 2022, an estimated $406K.
  • World Equity Group first reported a position in Moderna in Q1 2022 and held it in 3 quarters.
  • World Equity Group's Moderna position peaked at $577K in Q1 2022.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on World Equity Group's 13F filing for Q4 2022, filed 6 Sep 2024.